Suppr超能文献

川崎病的发病机制决定因素:血液学视角

Pathogenetic determinants in Kawasaki disease: the haematological point of view.

作者信息

Del Principe Domenico, Pietraforte Donatella, Gambardella Lucrezia, Marchesi Alessandra, Tarissi de Jacobis Isabella, Villani Alberto, Malorni Walter, Straface Elisabetta

机构信息

Department of Therapeutic Research and Medicine Evaluation, Section of Cell Aging and Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

Department of Neurosciences, Section of Cell Aging and Gender Medicine, Istituto Superiore di Sanità, Rome, Italy.

出版信息

J Cell Mol Med. 2017 Apr;21(4):632-639. doi: 10.1111/jcmm.12992. Epub 2017 Jan 7.

Abstract

Kawasaki disease is a multisystemic vasculitis that can result in coronary artery lesions. It predominantly affects young children and is characterized by prolonged fever, diffuse mucosal inflammation, indurative oedema of the hands and feet, a polymorphous skin rash and non-suppurative lymphadenopathy. Coronary artery involvement is the most important complication of Kawasaki disease and may cause significant coronary stenosis resulting in ischemic heart disease. The introduction of intravenous immunoglobulin decreases the incidence of coronary artery lesions to less than 5%. The etiopathogenesis of this disease remains unclear. Several lines of evidence suggest that an interplay between a microbial infection and a genetic predisposition could take place in the development of the disease. In this review, we summarize the state of the art of pathogenetic mechanisms of Kawasaki disease underscoring the relevance of haematological features as a novel field of investigation.

摘要

川崎病是一种可导致冠状动脉病变的多系统血管炎。它主要影响幼儿,其特征为持续发热、弥漫性黏膜炎症、手足硬性水肿、多形性皮疹和非化脓性淋巴结病。冠状动脉受累是川崎病最重要的并发症,可能导致严重的冠状动脉狭窄,进而引发缺血性心脏病。静脉注射免疫球蛋白的应用使冠状动脉病变的发生率降至5%以下。该疾病的发病机制仍不清楚。有几条证据表明,微生物感染与遗传易感性之间的相互作用可能在疾病发展过程中发生。在这篇综述中,我们总结了川崎病发病机制的最新研究状况,强调血液学特征作为一个新的研究领域的相关性。

相似文献

2
[Kawasaki syndrome, still a mystery].[川崎病,仍是一个谜]
Ned Tijdschr Tandheelkd. 2007 Oct;114(10):436-9.
3
[Kawasaki vasculitis].
Nihon Rinsho. 1994 Aug;52(8):2095-102.
4
Kawasaki disease.川崎病
Am Fam Physician. 1999 Jun;59(11):3093-102, 3107-8.
7
[Kawasaki disease].[川崎病]
Rev Prat. 1990 Dec 1;40(28):2604-8.
10
Kawasaki syndrome.川崎病
Semin Dermatol. 1992 Mar;11(1):37-47.

引用本文的文献

6
Markers of Endothelial Dysfunction in Kawasaki Disease: An Update.川崎病内皮功能障碍标志物:最新研究进展。
Clin Rev Allergy Immunol. 2024 Feb;66(1):99-111. doi: 10.1007/s12016-024-08985-5. Epub 2024 Mar 11.

本文引用的文献

4
Kawasaki disease: insights into pathogenesis and approaches to treatment.川崎病:发病机制的深入了解和治疗方法。
Nat Rev Rheumatol. 2015 Aug;11(8):475-82. doi: 10.1038/nrrheum.2015.54. Epub 2015 Apr 28.
5
Update of genetic susceptibility in patients with Kawasaki disease.川崎病患者遗传易感性的最新进展。
Korean J Pediatr. 2015 Mar;58(3):84-8. doi: 10.3345/kjp.2015.58.3.84. Epub 2015 Mar 20.
6
Kawasaki disease.川崎病。
Proc Jpn Acad Ser B Phys Biol Sci. 2006 Apr;82(2):59-71. doi: 10.2183/pjab.82.59.
8
Upcoming biomarkers for the diagnosis of Kawasaki disease: A review.川崎病诊断的新兴生物标志物:综述
Clin Biochem. 2015 Nov;48(16-17):1188-94. doi: 10.1016/j.clinbiochem.2015.02.013. Epub 2015 Mar 4.
10
Review: Annexin-A5 and cell membrane repair.综述:膜联蛋白A5与细胞膜修复
Placenta. 2015 Apr;36 Suppl 1:S43-9. doi: 10.1016/j.placenta.2015.01.193. Epub 2015 Feb 3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验